Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-04-06
1990-08-07
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514213, 540491, 540523, A61K 3155, C07D41712, C07D40512
Patent
active
049468405
ABSTRACT:
Vasodilating activity is exhibited by compounds having the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein X is --CH.sub.2 -- or --S--;
REFERENCES:
patent: 3562257 (1971-02-01), Kugita et al.
patent: 4567175 (1986-01-01), Takeda et al.
patent: 4584131 (1986-04-01), Floyd et al.
patent: 4590188 (1986-05-01), Takeda et al.
patent: 4694002 (1987-09-01), Floyd et al.
patent: 4748239 (1988-05-01), Floyd et al.
patent: 4752645 (1988-06-01), Das et al.
L. H. Werner et al., "Imidazoline Derivatives with Antiarrhythmic Activity" J. Med. Chem., 1967, 10, 575-582.
Barrish Joel C.
Kimball Spencer D.
Krapcho John
Bond Robert T.
E. R. Squibb & Sons Inc.
Gaul Timothy J.
LandOfFree
Benzazepine and benzothiazepine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzazepine and benzothiazepine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzazepine and benzothiazepine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960771